TextbookHaematologyFolate Deficiency

Folate Deficiency

Common cause of megaloblastic macrocytic anaemia due to reduced folate intake or increased demand. Unlike B12 deficiency, does NOT cause neurological damage. Critical in pregnancy for prevention of neural tube defects.

Key Facts

Macrocytic megaloblastic anaemia: identical haematological picture to B12 deficiency (oval macrocytes, hypersegmented neutrophils) NO neurological damage (unlike B12 deficiency) — key differentiating feature Causes: poor dietary intake (most common), increased demand (pregnancy, haemolytic anaemia, malignancy), malabsorption (coeliac, Crohn), drugs (methotrexate, trimethoprim, phenytoin, sodium valproate) Neural tube defects (NTDs): folic acid 400mcg daily pre-conception and for first 12 weeks of pregnancy reduces NTD risk by ~70% High-risk pregnancy: folic acid 5mg daily (previous NTD, diabetes, epilepsy on valproate/carbamazepine, BMI >30) Treatment: folic acid 5mg daily for 4 months; identify and treat underlying cause CRITICAL: always check B12 before starting folate — folate replacement in undiagnosed B12 deficiency may precipitate/worsen neurological damage (SACD) Red cell folate: more accurate than serum folate for tissue stores (less affected by recent intake)

Overview

Key Facts

Folate (vitamin B9) deficiency is a common cause of megaloblastic anaemia. Unlike B12 deficiency, it does not cause neurological damage. Folate supplementation in pregnancy is critical for preventing neural tube defects.

Epidemiology

  • Common: estimated ~5% of UK population may have suboptimal folate
  • Elderly, alcoholics, and lower socioeconomic groups at highest risk
  • Pregnancy: increased demand → deficiency common without supplementation

Aetiology

  • Dietary insufficiency (most common): poor intake of green vegetables, liver, fortified foods; alcoholism
  • Increased demand: pregnancy, lactation, haemolytic anaemia (sickle cell, thalassaemia), malignancy, psoriasis, exfoliative dermatitis
  • Malabsorption: coeliac disease, Crohn disease (proximal jejunum), tropical sprue
  • Drugs: methotrexate (DHFR inhibitor), trimethoprim, phenytoin, carbamazepine, sodium valproate

Pathophysiology

  • Folate is essential for one-carbon metabolism and DNA synthesis (thymidylate synthesis)
  • Deficiency → impaired DNA synthesis → megaloblastic erythropoiesis
  • Nuclear-cytoplasmic dissociation: delayed nuclear maturation with normal cytoplasmic maturation → large cells
  • Body stores last only 3–4 months (cf. B12 stores last 3–5 years)
  • Folate absorbed in proximal jejunum

Clinical Presentation

Haematological

  • Anaemia symptoms: fatigue, dyspnoea, pallor
  • Glossitis (smooth, red tongue)
  • Mild jaundice (ineffective erythropoiesis)

No Neurological Features

  • Key distinction from B12 deficiency
  • If neurological signs present: suspect B12 deficiency (or combined)

Red Flags

  • Neurological symptoms (suggests B12 deficiency — check both)
  • Pancytopenia (severe deficiency; exclude other causes)
  • Pregnancy with no folate supplementation (NTD risk)
  • Suspected coeliac disease (weight loss, diarrhoea, iron deficiency)

Differential Diagnosis

DiagnosisKey FeaturesInvestigation
B12 deficiencyNeurological damage (SACD), megaloblasticB12, MMA
HypothyroidismNon-megaloblastic macrocytosis, fatigueTFTs
Alcohol excessNon-megaloblastic macrocytosis, raised GGT/MCVGGT, history
MyelodysplasiaCytopenia, dysplastic cells on film, elderlyBone marrow biopsy
Liver diseaseMacrocytosis, deranged LFTsLFTs

Diagnosis / Investigation

Bloods

  • FBC: low Hb, raised MCV (>100 fL), ± pancytopenia
  • Blood film: oval macrocytes, hypersegmented neutrophils (identical to B12 deficiency)
  • Serum folate: low (<3 µg/L) — affected by recent dietary intake
  • Red cell folate: more reliable for tissue stores (low <150 µg/L) — but less commonly available
  • Serum B12: MUST check before starting folate (exclude B12 deficiency)
  • Homocysteine: elevated (non-specific)
  • MMA: NORMAL (distinguishes from B12 deficiency where MMA is elevated)
  • LDH, bilirubin: elevated (ineffective erythropoiesis)

Special Tests

  • Coeliac screen: anti-tTG (if unexplained folate deficiency)
  • Reticulocyte count: low

Management

Pharmacological

  • Folic acid 5mg daily for 4 months (standard treatment dose)
  • Identify and treat underlying cause (diet, coeliac, drugs)
  • CRITICAL: check and correct B12 deficiency BEFORE or alongside folate replacement

Pregnancy/Pre-conception

  • All women: folic acid 400mcg daily from pre-conception through first 12 weeks
  • High-risk (previous NTD, diabetes, BMI >30, epilepsy on valproate/carbamazepine, sickle cell/thalassaemia, coeliac): folic acid 5mg daily from pre-conception through first 12 weeks

Ongoing Supplementation

  • If cause is ongoing (haemolytic anaemia, chronic malabsorption): long-term folic acid 5mg daily
  • Methotrexate patients: folic acid 5mg once weekly (not on methotrexate day)

Dietary Advice

  • Green leafy vegetables (spinach, broccoli, Brussels sprouts)
  • Fortified cereals and bread
  • Liver, legumes, oranges

Referral Criteria

  • Haematology: pancytopenia, diagnostic uncertainty
  • Gastroenterology: suspected coeliac or malabsorption
  • Obstetrics: high-risk pregnancy

Prognosis

  • Excellent with appropriate replacement
  • Reticulocyte count rises within 5–7 days of starting treatment
  • Hb normalises within 6–8 weeks
  • Stores replenished within 4 months
  • Folate supplementation: reduces NTD risk by ~70% (400mcg); high dose (5mg) for high-risk
  • If underlying cause treated: folate deficiency unlikely to recur
  • Long-term folate needed if ongoing cause (haemolysis, malabsorption)

Other Relevant Information

Drugs Causing Folate Deficiency

DrugMechanism
MethotrexateInhibits dihydrofolate reductase (DHFR)
TrimethoprimInhibits bacterial DHFR (can affect human at high doses)
PhenytoinImpairs folate absorption
CarbamazepineImpairs folate absorption
Sodium valproateUnclear mechanism; NTD risk in pregnancy